ATE542531T1 - Nitrofuran-verbindungen zur behandlung von krebs und angiogenese - Google Patents

Nitrofuran-verbindungen zur behandlung von krebs und angiogenese

Info

Publication number
ATE542531T1
ATE542531T1 AT07752613T AT07752613T ATE542531T1 AT E542531 T1 ATE542531 T1 AT E542531T1 AT 07752613 T AT07752613 T AT 07752613T AT 07752613 T AT07752613 T AT 07752613T AT E542531 T1 ATE542531 T1 AT E542531T1
Authority
AT
Austria
Prior art keywords
compounds
angiogenesis
cancer
nitrofurane
treatment
Prior art date
Application number
AT07752613T
Other languages
English (en)
Inventor
Sholler Giselle Saulnier
Hema Sundaresha
Satyan Kalkunte
Rakesh Singh
Laurant Brard
Kyu Kim
Original Assignee
Women And Infants Hospital Of Rhode Island Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Women And Infants Hospital Of Rhode Island Inc filed Critical Women And Infants Hospital Of Rhode Island Inc
Application granted granted Critical
Publication of ATE542531T1 publication Critical patent/ATE542531T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07752613T 2006-03-16 2007-03-07 Nitrofuran-verbindungen zur behandlung von krebs und angiogenese ATE542531T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78275606P 2006-03-16 2006-03-16
PCT/US2007/005927 WO2007108947A2 (en) 2006-03-16 2007-03-07 Nitrofuran compounds for the treatment of cancer and angiogenesis

Publications (1)

Publication Number Publication Date
ATE542531T1 true ATE542531T1 (de) 2012-02-15

Family

ID=38522894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07752613T ATE542531T1 (de) 2006-03-16 2007-03-07 Nitrofuran-verbindungen zur behandlung von krebs und angiogenese

Country Status (7)

Country Link
US (2) US8470815B2 (de)
EP (1) EP2004177B1 (de)
CN (1) CN101500557B (de)
AT (1) ATE542531T1 (de)
AU (1) AU2007227692B2 (de)
CA (1) CA2646222C (de)
WO (1) WO2007108947A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009148623A2 (en) 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
CN104394854A (zh) * 2012-05-08 2015-03-04 美全诺药业 具有增强活性和降低毒性的包括硝呋替莫的硝基呋喃的新型制剂
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
EP3502700A1 (de) * 2017-12-21 2019-06-26 Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron Verfahren auf basis der erkennung von rad51 foki in tumorzellen
WO2019183385A1 (en) * 2018-03-22 2019-09-26 University Of Rochester Mapk/erk inhibition for ovarian and other cancers
CN108853114B (zh) * 2018-03-30 2019-12-24 天津奥溪利亚医药技术开发有限公司 硝呋莫司在制备治疗癌症衍生的脑转移瘤的药物中的应用
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN114377018B (zh) * 2020-10-21 2024-02-06 中国医学科学院药物研究所 硝呋莫司在制备抗流感病毒药物中的应用
CN112480097B (zh) * 2020-11-26 2022-07-08 汕头大学医学院 一种靶向ets结构域蛋白的抑制剂及其应用
CN115708822A (zh) * 2021-08-23 2023-02-24 南京施江医药科技有限公司 酰肼类药物在治疗肿瘤中的应用
CN119857136B (zh) * 2023-10-20 2026-08-07 天津济坤医药科技有限公司 一种抗cd84抗体在制备防治肺纤维化的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54151134A (en) * 1978-05-19 1979-11-28 Kureha Chem Ind Co Ltd Antitumorigenic agent
US5496830A (en) * 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
GB9601603D0 (en) * 1996-01-26 1996-03-27 Isis Innovations Ltd Terpyridine-platinum (II) complexes
CA2532250A1 (en) * 2003-07-15 2005-02-03 Barros Research Institute Compositions and methods for immunotherapy of cancer and infectious diseases
EP1537858A1 (de) * 2003-12-04 2005-06-08 Vectron Therapeutics AG Trägerstoffe zur Arzneistoffabgabe und deren Verwendung
WO2008091946A2 (en) 2007-01-24 2008-07-31 Women & Infants Hospital N-amino tetrahydrothiazine derivatives, method of manufacture and use

Also Published As

Publication number Publication date
WO2007108947A2 (en) 2007-09-27
AU2007227692B2 (en) 2012-09-13
CA2646222A1 (en) 2007-09-27
US9220714B2 (en) 2015-12-29
EP2004177A4 (de) 2009-11-18
US20110288080A1 (en) 2011-11-24
CA2646222C (en) 2016-07-05
US8470815B2 (en) 2013-06-25
US20130331383A1 (en) 2013-12-12
CN101500557B (zh) 2012-10-31
AU2007227692A1 (en) 2007-09-27
EP2004177B1 (de) 2012-01-25
WO2007108947A3 (en) 2008-04-24
CN101500557A (zh) 2009-08-05
EP2004177A2 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
WO2007108947A3 (en) Nitrofuran compounds for the treatment of cancer and angiogenesis
UA107783C2 (en) Isoindoline compounds for use in treating cancer
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
BRPI0915084B8 (pt) composto, e, composição farmacêutica
TW200800963A (en) Chemical compounds
EA201000946A1 (ru) Бициклические производные для применения при лечении состояний, связанных с андрогенным рецептором
ATE530540T1 (de) Pyrimidonverbindungen als gsk-3-inhibitoren
ATE497496T1 (de) 2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen
DE602004013563D1 (de) Rantagonisten
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
MX2009007104A (es) Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina.
TW200738724A (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200714604A (en) Substituted heterocycles and the uses thereof
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
SMT201200017B (it) Nuovi antagonisti P2X7R e il loro uso.
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
EA201170344A1 (ru) Азаиндольные ингибиторы iap
EA201000675A1 (ru) Производные хромана как модуляторы trpv3
ATE466841T1 (de) 1-phenethylpiperidinderivate und ihre verwendung als opioidrezeptor-liganden
TW200736189A (en) Indene derivatives, their preparation and use as medicaments
MX2009013482A (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.